ゼリア新薬工業
売上高
損益
EPS
利益率
コスト

損益計算書

2016-03千円
2017-03千円
2018-03千円
2019-03千円
2020-03千円
2021-03千円
2022-03千円
2023-03千円
2024-03千円
2025-03千円
2026-03千円
売上高62,475,03064,849,81364,568,68161,831,57860,426,74355,442,07359,532,82968,383,22775,725,07587,311,13789,159,262
売上原価17,930,38218,168,98118,341,89017,752,65516,643,61315,796,87917,384,57718,894,62720,223,75823,351,45123,976,621
売上総利益44,544,64846,680,83146,226,79044,078,92343,783,13039,645,19342,148,25149,488,60055,501,31763,959,68565,182,640
販売費及び一般管理費39,982,89242,149,61741,405,40940,334,03739,696,79336,192,76835,782,19240,473,62645,879,66951,762,10052,808,195
営業利益4,565,7554,541,5824,830,3993,737,0674,094,8243,442,0766,366,0589,014,9739,621,64712,197,58512,374,444
営業外収益
受取利息15,9067,0249,29514,42610,93332,13117,23967,887150,943282,871111,810
受取配当金198,680227,537179,541165,445192,188223,142192,216228,766287,817340,650366,366
為替差益--195,256------634,498-
その他137,707102,696106,034111,049107,276118,09778,05082,842119,081244,784302,001
償却債権取立益--------94,998--
営業外収益合計352,294337,258490,128290,921310,398373,371287,506379,496652,8401,502,805780,178
営業外費用
支払利息289,576267,169195,348199,645228,637238,195315,462337,281457,801452,290501,799
為替差損136,43478,500-450,612141,717322,794329,9901,416,6791,182,086-1,356,089
持分法による投資損失--------76,855276,717180,435
その他41,46394,85936,04981,83370,33279,44572,46561,05944,717130,51673,044
貸倒損失----85,191------
営業外費用合計467,473440,529231,397732,091525,879640,435717,9181,815,0201,761,460859,5242,111,369
経常利益4,450,5764,438,3115,089,1303,295,8973,879,3433,175,0115,935,6467,579,4498,513,02812,840,86511,043,254
特別利益
固定資産売却益4,2722,876-5,5563361,9913,5131,9162,2292,893417
投資有価証券売却益1,087,295807,574691,142400,06444,269375,14314,58919,940499,617-168,398
契約解除損失引当金戻入額--------977,204--
債務取崩益-----681,614-----
受取和解金---1,579,034-------
特別利益合計1,091,568810,451691,1421,984,65544,6051,058,74918,10321,8561,479,0512,893168,815
特別損失
固定資産売却損----3791,179---7542,075
固定資産除却損7,5309,0154,2886,4293,2914,0414,0276,1356,69315,7169,881
投資有価証券評価損118,684--------208,673-
のれん償却額--------476,992--
契約解除損失引当金繰入額-----------
契約解除損失引当金繰入額-----273,096227,958322,472---
減損損失143,733318,913-36,000-32,539-----
固定資産解体費用10,133--17,109-------
契約解除金--198,712--------
投資有価証券売却損-----------
買収調査費用-----------
特別損失合計280,082327,928203,00059,5393,670310,856231,985328,608483,685225,14511,956
税金等調整前当期純利益5,262,0614,920,8345,577,2715,221,0143,920,2773,922,9055,721,7647,272,6989,508,39412,618,61311,200,113
法人税、住民税及び事業税602,309600,441869,7621,061,027527,848837,063726,625823,2571,970,3822,663,2093,179,573
法人税等調整額1,127,482744,511524,482696,181453,618-45,6531,020,344242,629-157,196-12,601-396,599
法人税等合計1,729,7911,344,9531,394,2451,757,208981,467791,4091,746,9691,065,8871,813,1852,650,6082,782,973
当期純利益3,532,2703,575,8804,183,0263,463,8052,938,8103,131,4953,974,7946,206,8107,695,2089,968,0058,417,139
非支配株主に帰属する当期純利益又は非支配株主に帰属する当期純損失(△)18,77431,52025,2169,70713,43511,71013,60910,945-36,05331,682-37,404
親会社株主に帰属する当期純利益3,513,4963,544,3594,157,8103,454,0982,925,3753,119,7853,961,1846,195,8657,731,2629,936,3238,454,544
返品調整引当金戻入額62,38158,38148,01338,99546,81338,326-----
返品調整引当金繰入額58,38148,01338,99546,81338,32648,674-----
差引売上総利益44,548,64746,691,20046,235,80844,071,10543,791,61739,634,845-----